RA
CNMD icon

Rise Advisors’s CONMED CNMD Stock Holding History

Rise Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$77 – 367
2025
Q3 		$77 Hold
2
– – ﹤0.01% 1492
2025
Q2 		$85 Hold
2
– – ﹤0.01% 1506
2025
Q1 		$98 Sell
2
-141
-99% -$9.09K ﹤0.01% 1454
2024
Q4 		$9.8K Hold
143
– – ﹤0.01% 984
2024
Q3 		$10.3K Buy
143
+1
+0.7% +$71 ﹤0.01% 1006
2024
Q2 		$9.87K Hold
142
– – 0.01% 1019
2024
Q1 		$11.4K Buy
+142
New +$12.7K 0.01% 1021

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Rise Advisors's CNMD Position: Q4 2025 in Review

Rise Advisors sold out of CONMED (CNMD) in Q4 2025, closing a stake of 2 shares — an estimated $77 sold.

Rise Advisors first reported a position in CNMD in Q1 2024 and held it in 7 quarters. The position peaked at $11.4K in Q1 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Rise Advisors reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 2 CONMED shares in Q4 2025, an estimated $77.
  • Rise Advisors first reported a position in CONMED in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's CONMED position peaked at $11.4K in Q1 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.